Tarek El Moussa Just Shared An Update On His Back Injury, Saying “Miracles Happen” – HouseBeautiful.com
HouseBeautiful.com |
Tarek El Moussa Just Shared An Update On His Back Injury, Saying “Miracles Happen”
HouseBeautiful.com In early May, Flip or Flop star Tarek El Moussa suffered a serious back injury that left him struggling to walk. After weeks of stem cell therapy, Tarek took to Instagram to share that he’s almost fully recovered. “MIRACLES HAPPEN!!!!” he announced in … |
HouseBeautiful.com |
Tarek El Moussa Just Shared An Update On His Back Injury, Saying “Miracles Happen”
HouseBeautiful.com In early May, Flip or Flop star Tarek El Moussa suffered a serious back injury that left him struggling to walk. After weeks of stem cell therapy, Tarek took to Instagram to share that he’s almost fully recovered. “MIRACLES HAPPEN!!!!” he announced in … |
|
Dr. Htut on Immunotherapy in Multiple Myeloma
OncLive Htut says that he has a vested interest in immunotherapy—using PD-1/PD-L1 inhibitors to modify a patient’s immune system. Thus far, there has been a trial using the PD-1 inhibitor pembrolizumab (Keytruda) in myeloma. Unfortunately, there were some … |
Medical Xpress |
We’re not prepared for the genetic revolution that’s coming
Medical Xpress It is now possible to edit the human genome directly using a technique called CRISPR. Even though such genetic modification techniques are regulated, the relative simplicity of CRISPR means that biohackers are already using it to edit their own genomes … |
Medical Xpress |
We’re not prepared for the genetic revolution that’s coming
Medical Xpress It is now possible to edit the human genome directly using a technique called CRISPR. Even though such genetic modification techniques are regulated, the relative simplicity of CRISPR means that biohackers are already using it to edit their own genomes … |
WRAL Tech Wire |
FDA grants expedited status for bluebird bio’s gene therapy
WRAL Tech Wire DURHAM – bluebird bio, a gene therapy company with operations in Durham, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration for Lenti-D, its potential treatment for a rare and life-threatening neurological disorder … |